Choice of anticoagulant for treatment of pulmonary embolism • Malignancy - LMWH • To avoid parenteral therapy - Rivaroxaban; apixaban • Once a day oral therapy - Rivaroxaban; edoxaban; VKA • Hepatic involvement with coagulopathy - LMWH • Renal involvement with creatinine clearance <30 mL/min - VKA • Dyspepsia or history of Gl bleed - VKA, apixaban • Thrombolyzed patients - UFH • Need of reversal agent - VKA, UFH • Pregnancy - LMWH #anticoagulant #selection #decisionaid #vte #anticoagulation #pharmacology
